This is the authors' abstract. We don't add key points for this paper.
From the analysis, the following results were drawn: CXCL10 might be a potential prognostic biomarker and novel therapeutic target for ccRCC.
No takes yet. Share an insight, caveat, or question.
Qu et al. (2022) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: